Clinical Trials Browser

Phase 3 × OTHER × luspatercept × Clear all

NCT06927232 2025-04-15

AZA+Lus VS AZA Monotherapy in HR-MDS

Phase 3 Not yet recruiting

Higher-risk Myelodysplastic Syndrome